References
- Trevathan W. R., Smith E. O., McKenna J. J. eds. Evolutionary medicine. Oxford University Press, 1999.
- Dobzhansky T. Nothing in biology makes sense except in the light of evolution. American Biology Teacher, 1973, 35: 125–129.
- Swynghedauw B. Molecular cardiology for the cardiologist. Kluwer Acad. Press. Boston, 1998.
- Carroll S. B. Genetics and the making of Homo sapiens. Nature, 2003, 422: 849–857.
- Nisbel E. G., Sleep N. H. The habitat and nature of early life. Nature, 2001, 409: 1083–1091.
- Balavoine G. L’évolution des animaux et l’origine du cerveau. In: Gènes et culture. Changeux J. P. (ed.). Paris: Odile Jacob., 2003: p. 73–91.
- Cavalli-Forza L. L., Feldman M. W. The application of molecular genetic approaches to the study of human evolution. Nature Genetics supplement, 2003, 33: 266–275.
- Owens K., King M. C. Genomic views of human history. Science, 1999, 286: 451–453.
- Lewontin R. C. The apportionment of human diversity. Evol Biol, 1972, 6: 381–398.
- Swynghedauw B. Human races and evolutionary medicine. Eur Rev, 2003, 11: 437–447.
- James S. A. Confronting the moral economy of US racial/ethnic health disparities. Am J Public Health, 2003, 93: 189.
- Ameisen J. C. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ, 2002, 9: 367–393.
- Swynghedauw B., BesseS., HeymesC., AssayagP. Système cardiovasculaire du sujet âgé normal. CR Acad Sc (Paris), 2002, 325: 683–691.
- Bach J. F. The effects of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med, 2002, 347: 911–920.
- Eaton S. B., Konner M. J., Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med, 1988, 84: 739–749.
- Cordain L., Gotshall R. W., Eaton S. B., Eaton S. B. III. Physical activity, energy expenditure and fitness: an evolutionary perspective. Int J Sports Med, 1998, 19: 328–335.
- Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev, 1999, 79: 215–262.
- Acar J., Bodnar E. eds. Textbook of acquired heart valve disease. London: ICR Publishers., 1995.
- Hoshijima M., Chien K. R. Mixed signals in heart failure: cancer rules. J Clin Invest, 2002, 109: 849–855.
- Swynghedauw B. Myocardial remodelling: pharmacological targets. Expert Opin Invest Drugs, 2002, 11: 661–674.
- Erdös T., Butler-Browne G. S., Rappaport L. Mechanogenetic regulation of transcription. Biochimie (Paris), 1991, 73 :1219–123.
- Samuel J. L., Bertier B., Bugaisky L., Marotte F., Swynghedauw B., Schwartz K., Rappaport L. Different distributions of microtubules, desmin filaments and isomyosins during the onset of cardiac hypertrophy in the rat. Eur J Cell Biol, 1984, 34: 300–306.
- Swynghedauw B., Charlemagne D. What is wrong with positive inotropic drugs: lessons from basic science and clinical trials. Eur Heart J, 2002, 4 (suppl D), D43–D49.
- Greaves M. Cancer causation: the Darwinian downside of past success ? Lancet Oncology, 2002, 3: 244–251.
- Swynghedauw B. Susceptibility-conferring polymorphic genotypes in cardiovascular multifactorial syndromes. Eur Heart J, 2002, 23: 271–273.
- Calle E. E., Rodriguez C., Walker-Thurmond K., Thun W. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med, 2003, 348: 1625–1638.
- Writing Group of the WHI investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA, 2002, 288: 321–333.